@m-faiza1. also Tracvirus which is also ready for tracking/management of vaccination record online.
.....“Vaccine bottles using Arita Covid-19 vaccine plastic sheet came with Tracvirus vaccine record tracking App, a global unified electronic certification (E-Cert) for International travel, social, work and school Covid-19 test and vaccine record anti-fraud and anti-fake verification solution,” the firm added.,,,,,
Therefore I keep dreaming as the company can explore more in vaccines businesess, not only supplying vaccine bottle but also managing vaccine record (via their Tracvirus). At last but not the least, it also has the capability in distributing Covid-19 vaccine.
""NMed Bioscience Sdn Bhd‘s subsidiary Vaccines Lab Sdn Bhd with the focus in South East Asia human vaccine clinical trial, registration (THROUGH TRACVIRUS APP ?????? ) , and distribution (THERE IS MY POINT???????), cooperating with vaccine developers around the world for safe and effective vaccines sourcing.""
Conclusion: I have many reasons to DREAM that Nexgram has many capabilities to be involve in Covid-19 VACCINE businesses because of their readiness with: 1. Tracvirus (involving covid-19 testing and also can be used in tracking online about individual covid-19 vaccination information), 2. Their subsidiary also involve in vaccine activities, 3. Their subsidiary's ability to produce and supply vaccine bottles 4. Their close contact with MOH
----------------------------------- To add one more point: 5. Their close contact with Shanghai Fosun and Fosun Malaysia
Don't worry, base on chart showing start beginning uptrend. Ochimoku cloud start green. Estimate within this few days, start up again. This is normal correction unless broke downtrend. To newbie, I'm advice study technical instead of follow blindly what peopke say. Especially hater... If know technical, it will guide you to do what you need to do.
Excerpt: 13 August 2020, Kuala Lumpur – Medical device provider Nexgram Holdings Bhd (Nexgram Group) is acquiring medical plastic firm Arita Plastics Industries (M) Sdn Bhd (Arita) in a move to enter manufacturing and supply of biomedical materials, life-saving medical devices, medical compounds, and personal protective equipment such as protection face shield, hospital Acrylic (PMMA) Medical Intubation boxes and gloves, and Acrylic sheets as alternative material to borosilicate glass vials for COVID-19 Vaccines.........
.......“Vaccine bottles using Arita Covid-19 vaccine plastic sheet came with Tracvirus vaccine record tracking App, a global unified electronic certification (E-Cert) for International travel, social, work and school Covid-19 test and vaccine record anti-fraud and anti-fake verification solution,” the firm added.
Yesss. No Sweat... Go Go Go Nexgrammmmmm Magnificient achievement from Nexgram: Tracvirus4Malaysia NexgramBottleVaccine Tracvirus with tracking vaccination is ready and Covid-19 vaccine distri................ (a possibility)
FIERCE & FURIOUS START...... DARLING NECGRAM COMPLETE ALL ROUNDER COVID BIZ INCLUDING VACCINE #THE CHEAPEST COVID STOCK....NEXT. "AT " IN THE MAKING $$$
What is TracVirus? Product of Tri-G Technologies Sdn Bhd (a subsidiary of public listed company Nexgram Holdings Bhd with Malaysia Medical Device Authority (MDA) medic distributor licenses)
Real-time COVID-19 Fraud & Fake E-Certificate check Internet and mobile access to QR Code tracking for employer, authorities, world wide Access & download at tracvirus.com or app.tracvirus.com
"SERVICING 3,600 Clinics, GPs, Hospitals, and Medical service providers PCR TEST CAPACITY of 10,000 pax per day" (as of 5 June 2020)
Khairy: Malaysia will participate in global Covid-19 vaccine development platform Covax Thursday, 19 Nov 2020 10:39 AM MYT
Minister of Science, Technology, and Innovation Khairy Jamaluddin speaks during a press conference in Kuala Lumpur August 14, 2020. — Picture by Firdaus Latif Minister of Science, Technology, and Innovation Khairy Jamaluddin speaks during a press conference in Kuala Lumpur August 14, 2020. — Picture by Firdaus Latif KUALA LUMPUR, Nov 19 — The government will participate in the global Covid-19 vaccine development platform Covax, Science, Technology and Innovation Minister Khairy Jamaluddin said today.
Khairy said it had been agreed during a Cabinet meeting on November 13 that Malaysia through the Health Ministry (MoH) will finalise its participation in the Covax facility.
“The Cabinet agreed on November 13 that Malaysia through MoH will finalise its participation in the Covax facility by signing an optional purchase agreement.
“For now, MoH and Gavi (Global Alliance Vaccination and Immunisation) are finalising a date to sign the agreement,” Khairy told the Dewan Rakyat today during Ministers’ Question Time.
Khairy said participation in the facility will cost Malaysia US$22,656,200, or approximately RM94.08 million, in the form of an upfront payment and risk sharing guarantee.
According to Khairy, the Cabinet had on October 14 agreed that Malaysia should join Covax which will guarantee Covid-19 vaccinations for 10 per cent of Malaysians.
“The Cabinet also agreed that the MoH, representing Malaysia, will finalise the agreement on Malaysia’s participation in the Covax facility with Gavi, and the Attorney General’s Chambers has been tasked with reviewing the terms and conditions set by Gavi.
“The guarantee for early access to the Covid-19 vaccine is important as it will protect Malaysians from Covid-19 and help boost the economy when ‘vaccination’ becomes a byword for mobility and global interactions,” he said.
He added that Malaysia’s participation in the multilateral Covax facility is a multi-pronged approach that will open up more (vaccine) options for the country and reduce the risk of being only dependent on a bilateral acquisition of the Covid-19 vaccine.
In September, the Ministry of Science, Technology and Innovation (Mosti) said the government was also preparing an agreement to join the Coalition for Epidemic and Preparedness Innovations (Cepi) as well as government-to-government agreements with Beijing for access to vaccines set to be developed by pharmaceutical firms in China.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
Report Abuse
Please Sign In to report this post as abuse.
Market Buzz
No result.
Featured Posts
MQ Trader
Introducing MY's First IPO Fund for Sophisticated Investors!
MQ Chat
New Update. Discover investment communities that resonate with your ideas
MQ Trader
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
0:17
New IPO: Supreme Consolidated Resources Berhad, a distributor and warehouser of F&B products, aims to list on the ACE Market!
MQ Trader 691 views | 12 d ago
0:17
New IPO: O&G healthcare service provider, Metro Healthcare Berhad aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Jun Carrie Oakey
9 posts
Posted by Jun Carrie Oakey > 2020-11-18 21:19 | Report Abuse
Pfizer = Fosun = Nexgram
https://www.nbcnews.com/health/health-news/pfizer-biontech-seek-covid-19-vaccine-approval-within-days-trial-n1248079
Now 0.055, if you lucky you can grab some tomorrow morning if not we see you at the top.